logo
ProjectSigned

PRIOTHERA (EGF VD)

Signed · Ireland

Source: European Investment Bank (EIB)

Priothera is a clinical stage company developing receptor modulators for haematologic malignancies, i.e. cancers that affect blood, bone marrow, and lymph nodes (e.g. leukaemia). Priothera is developing a novel drug, mocravimod for acute myeloid leukaemia (AML) with an aim of enhancing the curative potential of Hematopoietic Stem Cell Transplantation (HSCT).

Status
Under Construction
Sector
Government
Location
Ireland
Updated
22 Jul 2026
Source
European Investment Bank (EIB)

ConstructChat

Ask ConstructChat about PRIOTHERA (EGF VD)

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

4 Q
The project “PRIOTHERA (EGF VD)” is an infrastructure initiative in the Government sector, located in Ireland. Taiyo aggregates data on it from European Investment Bank (EIB).

Participants

Sponsoring Agency

Status

Original status

signed

Taiyo status

Under Construction

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

Priothera is a clinical stage company developing receptor modulators for haematologic malignancies, i.e. cancers that affect blood, bone marrow, and lymph nodes (e.g. leukaemia). Priothera is developing a novel drug, mocravimod for acute myeloid leukaemia (AML) with an aim of enhancing the curative potential of Hematopoietic Stem Cell Transplantation (HSCT).

Original sector

Services

Location

Country

Ireland

Source

Source

European Investment Bank (EIB)

URL

More Details

Record type

Project

Sector

Government

Article published date

2025-07-28

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project